The financing was led by EMV Capital Partners and will support operational scaling and early customer deployments.
"We are pleased to have secured this significant investment from our existing shareholder base, and to welcome NSSIF as a new strategic shareholder. This support is a testament to the disruptive potential of Sofant’s technology and the remarkable progress our team has made in recent months. With this additional capital, we are positioned to accelerate our commercial deployment and redefine what is possible in wireless communications."
SFC Capital led the round with backing from the University of Strathclyde and Scottish Enterprise.
"The wellbeing of those who serve on the front lines is paramount. Sentinel exists to ensure that the people who protect and care for others receive the same care in return. This investment allows us to expand our impact and further develop our evidence-based tools for trauma prevention, management and recovery."
The financing will support clinical material manufacture and preparation for regulatory studies ahead of a target marketing authorisation application.
"This additional funding represents strong continued confidence in our technology platform and our progress towards commercialisation. The support from Archangels, Scottish Enterprise and BBB Investments is enabling us to advance our clinical and manufacturing capabilities as we work towards regulatory approval."
The funding round includes backing from prominent angel investors and will support growth in the UK and US markets.
"We have seen first-hand that most enterprises are losing revenue through tech skill shortages, with the rise in AI accelerating that challenge. By combining internal employees, external freelancers and pre-built AI Agents our technology is helping tech leaders fill skill gaps quickly."
.png)
